Watch
Your Health Matters

Actions

Medicare is looking to see if they should provide coverage for the new Alzheimer's drug

items.[0].image.alt
AP
FILE - This image provided by Biogen on Monday, June 7, 2021 shows a vial and packaging for the drug Aduhelm. On Thursday, July 8, 2021, U.S. health regulators approved new prescribing instructions for the controversial Alzheimer's drug that are likely to limit use of the expensive therapy, which has faced an intense public backlash. (Biogen via AP, File)
Alzheimer Drug
Posted at 6:42 AM, Jul 14, 2021
and last updated 2021-07-14 09:43:03-04

BAKERSFIELD, Calif. (KERO) — Medicare is currently looking at whether is should cover the new Alzheimer's drug, aduhelm.

The drug comes with a $56,000 yearly price tag. It's also been criticized for not having enough evidence showing that it is beneficial to Alzheimer's patients.

A final decision on coverage isn't expected until spring of next year, but an initial ruling could happen before then.

Copyright 2021 Scripps Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
If You Give a Child a Book

If You Give a Child a Book